ZNF416 and pulmonary fibrosis: ​Consistently, the administration of ZNF416 siRNA-loaded liposomes could also attenuate BLM-induced pulmonary fibrosis, which was evidenced by qRT-PCR, western blot, H&E, Masson trichrome and Sirius red staining, immunofluorescence and hydroxyproline assays (Additional file 1: Fig. S7A–H).